Skip to content
News Center
About Us Careers News Center Contact Us Legal Doing Business with Illumina Investors Illumina for Startups Customer Engagement Center

Corporate

Video: A Conversation with Illumina's President and CEO

Francis deSouza reveals his motivations, inspirations and what's next at Illumina

A Conversation with Illumina's President and CEO
July 6, 2016

Francis deSouza's first one-on-one interview as President and CEO of Illumina.

Previous Article
Next Article

Recent articles

What is transcriptomics? A complete guide to gene expression analysis
What is transcriptomics? A complete guide to gene expression analysis
At Michigan Medicine, WGS becomes the backbone of molecular pathology
At Michigan Medicine, WGS becomes the backbone of molecular pathology
Geraldine Bliss wants parents to ask, “Could it be genetic?”
Geraldine Bliss wants parents to ask, “Could it be genetic?”
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.